Abstract:AIM To evaluate bioequivalence of lansoprazole and its metabolites 5-hydroxy lansoprazole and lansoprazole sulphone in 22 healthy male vounteers after a single oral dose of 30 mg.METHODS LC:using Diamonsil C_(18) column(250 mm×2.1 mm,5 μm)with preliminary column Octadecy1 C_(18)(4.0 mm×3.05 mm);the mobile phase consiting of acetonitrile-2 mmol·L~(-1) ammonium acetate solution(60∶40,V/V);the flow rate was 0.2 mL·min~(-1);and the column temperature was 40℃.MS:using electrospray ionization (ESI),and selected ion mass spectral (m/z) 368.1/164.1 (lansoprazole),384.0/180.0 (5-hydroxylansoprazole),384/115.9 (lansoprazole sulphone),364.1/188.1(internal standard)to quantify.The plasma samples were treated with acetonitrile precipitation.RESULTS The pharmacokinetic parameters of lansoprazole (test) were:AUC:(12 989.16±13 356.96)μg·h·L~(-1),c_(max)(2 780±1 282)μg·L~(-1),t_(max):(1.73±0.74)h,T_(1/2):(2.74±2.01)h;5-hydroxy lansoprazole(test) were:AUC:(197.51±68.54)μg·h·L~(-1),c_(max):(73.45±39.09)μg·L~(-1),t_(max):(1.59±(0.76))h,T_(1/2):(3.26±1.97)h;lansoprazole sulphone (test) were:AUC:((1 496.74)±2 517.81)μg·h·L~(-1),c_(max):(160.75±146.12)μg·L~(-1),t_(max):(2.18±1.55)h,T_(1/2):(2.94±3.48)h.The pharmacokinetic parameters of lansoprazole (reference) were:AUC:(13 426.99±3 671.51)μg·h·L~(-1),c_(max):(2 945±(1 383))μg·L~(-1),t_(max):(1.90±0.63)h,T_(1/2):(2.53±2.06)h;5-hydroxy lansoprazole (reference) were:AUC:(211.77±(78.40))μg·h·L~(-1),c_(max):(77.70±43.78)μg·L~(-1),t_(max):(1.83±0.65),T_(1/2):(3.03±1.77)h;lansoprazole sulphone (reference) were:AUC:(1 510.80±2 525.48)μg·h·L~(-1),c_(max):(169.20±151.28)μg·L~(-1),t_(max):(2.27±1.37)h,T_(1/2):(2.64±2.96)h.There were no significant differences in all pharmacokinetic parameters between 2 capsules.(P>0.05).CONCLUSION The results of two one-side test show that 2 preparations are bioequivalent.

Bioequivalence of Lansoprazole Enteric Caspsules in Healthy Volunteers

Bioequivalence of lansoprazole and its metabolites

Studies on the Bioequivalence of Lorazepam Tablet in Healthy Volunteers

Study on bioequivalence of cilostazol table in healthy volunteers

Studies on Bioequivalence of Ramipril Capsule in Healthy Volunteers

Bioequivalence of Pantoprazole Sodium Enteric-Coated Capsules in Human

Study on bioequivalence of pravastatin sodium tablets in healthy volunteers

[Pharmacokinetics and Relative Bioavailability of Ziprasidone Tablets in Chinese Healthy Volunteers].

Bioequivalence Evaluation of Two Rabeprazole Enteric Coated Formulations in Healthy Chinese Volunteers

The effect of CYP2C19 activity on pharmacokinetics of lansoprazole and its active metabolites in healthy subjects.

Bioequivalence study of fluoxetine capsules in healthy volunteers

Determination of Lansoprazole in Human Plasma by Rapid Resolution Liquid Chromatography–electrospray Tandem Mass Spectrometry: Application to a Bioequivalence Study on Chinese Volunteers

Bioequivalence of Glipizide Controlled-Release Tablets in Chinese Healthy Volunteers

Bioequivalence of Azithromycin Tablets in Healthy Volunteers

Bioequivalence of Levodopa Tablets in Healthy Volunteers

Pharmacokinetics and bioequivalence of roxithromycin capsules in healthy volunteers

Pharmacokinetics and Bioequivalance of Ambroxol Dispersible Tablets in Healthy Volunteers

Pharmacokinetics and bioequivalence study of escitalopram oxalate formulations after single-dose administration in healthy Chinese male volunteers

Comparative bioavailability of two escitalopram formulations in healthy human volunteers

Study on Bioequivalence of Ciclosporin Microemulsion Oral Solution in Healthy Volunteers

LC-MS/MS Method for Simultaneous Quantitation of Lansoprazole and Its Metabolites in Human Plasma and Application to a Pharmacokinetic Study